PRISCO, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 32.172
EU - Europa 20.789
AS - Asia 11.638
SA - Sud America 2.042
AF - Africa 363
OC - Oceania 276
Continente sconosciuto - Info sul continente non disponibili 10
Totale 67.290
Nazione #
US - Stati Uniti d'America 31.870
RU - Federazione Russa 7.548
PL - Polonia 4.036
SG - Singapore 3.571
CN - Cina 2.317
HK - Hong Kong 2.268
IE - Irlanda 1.942
IT - Italia 1.918
BR - Brasile 1.660
SE - Svezia 1.625
KR - Corea 1.301
DE - Germania 1.051
UA - Ucraina 773
VN - Vietnam 687
FI - Finlandia 656
IN - India 454
GB - Regno Unito 453
FR - Francia 307
AU - Australia 269
JO - Giordania 200
TR - Turchia 192
CA - Canada 185
AR - Argentina 160
JP - Giappone 136
ID - Indonesia 135
CH - Svizzera 106
CI - Costa d'Avorio 89
ES - Italia 81
ZA - Sudafrica 81
NL - Olanda 74
BD - Bangladesh 72
MX - Messico 70
EC - Ecuador 67
IQ - Iraq 63
AT - Austria 48
BE - Belgio 42
MA - Marocco 39
PK - Pakistan 35
CO - Colombia 34
VE - Venezuela 34
SC - Seychelles 32
SA - Arabia Saudita 31
PY - Paraguay 30
BJ - Benin 28
CZ - Repubblica Ceca 26
UZ - Uzbekistan 24
CL - Cile 22
EG - Egitto 19
KE - Kenya 18
AZ - Azerbaigian 17
LT - Lituania 15
TN - Tunisia 15
IR - Iran 13
NP - Nepal 13
PE - Perù 13
UY - Uruguay 13
DZ - Algeria 12
DK - Danimarca 11
KZ - Kazakistan 11
IL - Israele 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
OM - Oman 9
PH - Filippine 9
BO - Bolivia 8
PT - Portogallo 8
EU - Europa 7
GT - Guatemala 7
HN - Honduras 7
LV - Lettonia 7
MU - Mauritius 7
NZ - Nuova Zelanda 7
BG - Bulgaria 6
ET - Etiopia 6
GR - Grecia 6
HU - Ungheria 6
RO - Romania 6
SN - Senegal 6
JM - Giamaica 5
KH - Cambogia 5
NO - Norvegia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
CR - Costa Rica 4
GE - Georgia 4
MM - Myanmar 4
PA - Panama 4
PS - Palestinian Territory 4
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
Totale 67.247
Città #
Santa Clara 6.647
Warsaw 4.032
Fairfield 3.249
Ashburn 2.803
Singapore 2.377
Dublin 1.923
Hong Kong 1.870
Chandler 1.797
Woodbridge 1.490
Seattle 1.304
Seoul 1.295
Jacksonville 1.225
Cambridge 1.220
Houston 1.180
Wilmington 1.054
Beijing 698
San Jose 539
Los Angeles 525
Ann Arbor 520
Hefei 516
Lawrence 506
Princeton 501
Buffalo 489
Altamura 472
Florence 368
Boston 339
Mumbai 316
Moscow 310
Boardman 283
Munich 266
Melbourne 262
Dallas 244
Medford 243
New York 243
The Dalles 233
Ho Chi Minh City 231
Helsinki 192
San Diego 191
Paris 180
Shanghai 141
São Paulo 139
Kent 124
Hanoi 122
Tokyo 122
Turku 114
London 97
Bern 94
Jakarta 91
Abidjan 89
Norwalk 86
Milan 81
Clifton 80
Toronto 80
Izmir 78
Dong Ket 76
Falls Church 73
Redondo Beach 62
Hillsboro 56
Rio de Janeiro 56
Chicago 53
Rome 52
Phoenix 50
Frankfurt am Main 48
Montreal 46
Council Bluffs 44
Andover 43
Auburn Hills 43
Barcelona 43
Brooklyn 43
Vienna 43
Brussels 41
Johannesburg 40
Stockholm 40
Tianjin 40
Yubileyny 39
Belo Horizonte 35
Denver 35
Orem 35
Chennai 33
Frankfurt Am Main 31
Curitiba 30
Haiphong 30
Guangzhou 29
Poplar 29
Cotonou 28
Redwood City 28
West Jordan 28
Brasília 26
Dearborn 26
Latina 26
Porto Alegre 26
Verona 26
Da Nang 25
Baghdad 24
San Francisco 24
Atlanta 23
Bengaluru 23
Casablanca 23
Salerno 22
Biên Hòa 21
Totale 45.388
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 434
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 337
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 336
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 336
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 314
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 297
A severe case of warfarin-canrenoate interaction: a role for genetic predisposition? 297
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 294
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 287
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 283
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarction 282
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 272
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 270
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 269
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis 266
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 266
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. 265
D-dimer concentrations during normal pregnancy, as measured by ELISA 264
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS(2) score 261
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment 258
Vascular and connective tissue features in 5 italian patients with homocystinuria 257
Apolipoprotein(a) kringle-IV type 2 copy number variation is associated with venous thromboembolism 256
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. 253
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 251
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 248
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 248
T cells in gastric cancer: friends or foes. 245
Perioperative assessment of platelet function by Thromboelastograph Platelet MappingTM in cardiovascular patients undergoing non-cardiac surgery 241
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 241
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 239
D-Dimer in intra-uterine growth retardation and gestational hypertension 237
Perioperative myocardial infarction in elderly patients with hip fracture. Is there a role for early coronary angiography? 233
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 225
Aumentata produzione di trombossano A2 e di PGE2 con normale conversione di 1-14 C acido arachidonico da parte delle piastrine nei soggetti diabetici. 224
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 224
Cardiac prostaglandin synthesis in spontaneous and in effort angina 221
Point-of-care testing of hemostasis in cardiac surgery 219
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 219
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 217
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 214
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 214
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 213
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 212
D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study 208
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 205
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 205
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism 201
Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina 201
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 198
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 198
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 196
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 196
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 196
Thrombosis in vasculitis: from pathogenesis to treatment 194
Hip fracture unit: beyond orthogeriatrics 193
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 193
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 191
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 191
Early changes of the endothelial antithrombotic properties in cholesterol fed rabbits. II Changes of heparansulphate and other GAGS 189
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 188
Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina 187
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes 187
Gastric cancer and the epoch of immunotherapy approaches 183
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 183
Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus 181
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis 181
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 181
Important risk factors for venous thromboembolism. Analysis of 758 patients studied at a thrombosis center 178
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: An italian experience 178
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the prolong study 178
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 177
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 176
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 176
Acute T-cell activation is detectable in unstable angina 175
Ability of whole blood aggregometer to detect platelet hyperaggregability 175
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. 175
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. 175
Impaired cardiac PGI2 and PGE2 biosynthesis in patients with angina pectoris 174
D-dimer plasma levels during normal pregnancy measured by specific ELISA 174
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 174
Acute coronary syndromes with significant troponin increase in patients with hip fracture prior to surgical repair: differential diagnosis and clinical implications 174
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 174
Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study 173
Spontaneous and cold pressor test-induced prostaglandin biosynthesis by human heart 173
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. 173
Age related changes in platelet lipid composition 173
TISSUE FACTOR AND HOMOCYSTEINE LEVELS IN ISCHEMIC HEART DISEASE ARE ASSOCIATED WITH ANGIOGRAPHICALLY DOCUMENTED CLINICAL RECURRENCES AFTER CORONARY ANGIOPLASTY 172
Role of haemorheological factors in patients with retinal vein occlusion. 172
Fibrinolysis alterations in infertile women during controlled ovarian stimulation: Influence of BMI and genetic components. 171
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 171
The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) 171
Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes 170
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 170
Altered fibrin susceptibility to plasmin-induced lysis in coronary artery disease patients: relationships with oxidative stress 170
"In Less than No Time": Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy 169
Blood clotting activation during normal pregnancy 169
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 169
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 168
The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty 167
Lp(a): a new risk factor for deep venous thrombosis? 167
Totale 21.566
Categoria #
all - tutte 192.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.484 0 0 0 0 0 0 228 426 473 663 288 406
2021/20223.303 88 201 321 155 139 177 100 250 191 126 619 936
2022/20237.923 824 1.491 353 488 605 1.456 1.053 412 773 63 234 171
2023/20243.077 115 329 572 175 199 466 103 585 46 163 156 168
2024/202520.133 677 2.166 1.290 3.134 5.685 2.537 333 1.134 1.076 626 737 738
2025/202613.945 2.471 3.095 1.878 2.194 2.511 941 855 0 0 0 0 0
Totale 67.782